Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model

NCT01527188 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

355

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis Due to House Dust Mite

Interventions

DRUG: 100 IR house dust mites allergen extract tablet
DRUG: 300 IR house dust mites allergen extract tablet
DRUG: 500 IR house dust mites allergen extract tablet
DRUG: Placebo tablet

Sponsor

Stallergenes Greer